Autolus Therapeutics (AUTL) Other Operating Expenses (2017 - 2025)
Autolus Therapeutics (AUTL) posted quarterly Other Operating Expenses of $25.3 million for Q4 2025, up 844333.33% on a QoQ basis from -$3000.0 in Q1 2025.
Autolus Therapeutics (AUTL) Other Operating Expenses (2017 - 2025) Analysis & Trends
Autolus Therapeutics (AUTL) has reported Other Operating Expenses for 7 consecutive years, with $25.3 million the latest figure, recorded in Q4 2025.
- Quarterly Other Operating Expenses changed N/A year-over-year to $25.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $25.3 million (up 11456.05% YoY) and the FY2025 annual result came in at $96.4 million, up 43314.8% from the prior year.
- Other Operating Expenses improved to $25.3 million in Q4 2025 per AUTL's latest filing, from -$3000.0 in the prior quarter.
- Over the last five years, Other Operating Expenses for AUTL reached as high as $25.3 million in Q4 2025 and fell as low as -$3.8 million in Q1 2023.
- A 4-year average of $3.5 million and a median of -$123000.0 in 2023 frame the typical range for Other Operating Expenses.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Autolus Therapeutics | 404.53 Mn | 103.82 Mn | -1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 25.33 Mn |
| Mar 31, 2025 | -3,000.00 |
| Sep 30, 2024 | -223,000.00 |
| Jun 30, 2023 | -23,000.00 |
| Mar 31, 2023 | -3.77 Mn |
| Dec 31, 2022 | -515,000.00 |
| Jun 30, 2019 | -2.30 Mn |
| Dec 31, 2018 | 685,000.00 |
| Sep 30, 2018 | 31.75 Mn |
| Jun 30, 2018 | -869,000.00 |
| Dec 31, 2017 | -231,000.00 |